Peritoneal neoplasm

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
1 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Taxane 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Corcept Therapeutics Inc. Commercial
    PACLITAXEL ALBUMIN-BOUND; RELACORILANT
    2024-514080-25-00 6 countries 2023 n=205 Orphan
    Ended

Phase II

1 trial
  • Corcept Therapeutics Inc. Commercial
    RELACORILANT
    2024-517432-21-00 6 countries 2025 n=177 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Corcept Therapeutics Inc. Commercial 2 Phase II, Phase III 1
New trials by year
2023
1
2025
1
← All indication landscapes